Blincyto

Made by

• Amgen
• Astellas Pharma

Active Ingredient

Blinatumomab (genetical recombination)

Prospectus

Approval date

2018/9/21

Treats

• B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia

Dosages

• BLINCYTO For I.V. Infusion 35μg - 286336円／瓶